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Description of
Need

 PSA screening to detect early asymptomatic prostate cancer is a
controversial practice. While screening has been shown to
increase detection years earlier than symptoms develop, a
mortality benefit has been harder to show. The practice also leads
to many false positive results and unnecessary biopsies.
 Both the USPSTF and American Urological Association currently
recommend the choice to screen in average risk individuals be
based off the personal values and goals of the patient.
 This is a complicated decision to make as a patient and a difficult
conversation to facilitate for the doctor because there is good
evidence for and against the practice.

 Prostate Cancer is the most common cancer that affects men and
is the second leading cause of cancer death in men.

Public Health
Cost

 PSA-based screening programs in men ages 55 to 69 years may
prevent up to 1 to 2 deaths from prostate cancer over
approximately 13 years per 1,000 men screened. Screening
programs may also prevent up to 3 cases of metastatic prostate
cancer per 1,000 men screened over 13 years.
 Follow-up of large randomized trials suggests that 20% to 50% of
men diagnosed with prostate cancer through screening may be
“over-diagnosed” (treatment of cancer that would never have
been symptomatic).

Community
Perspective

 Dr. Jordan Kurta, a Urologist at CMMC, believes that PSA
screening is an effective tool to help assess prostate cancer risk
but acknowledges that different physicians use this tool
differently.
 Family Medicine Physicians at CMMC currently use the AUA and
USPSTF recommendations to discuss PSA screening with their
patients and initiate screening based on these conversations.
 Given the recent changes in recommendations from the USPSTF
in both 2012 and 2017 it can be hard to keep up with the most
recent evidence

Intervention
and
Methodology

 A short, easy to read handout that patients can use to help them
understand the risks and benefits of choosing to screen covering
the following topics
 Personal risk factors
 Potential side effects of treatment
 Risk of false positives and unnecessary treatment

Results/Respo
nse

 A take-home handout for patients to review the risks and benefits
of PSA screening and how their own personal values effect the
choice to screen.
 Refresher handout of the USPSTF and AUA’s most recent
recommendations for PSA testing for providers at CMMC family
medicine residency

Effectiveness
and
Limitations

 Handout allows patient’s to digest the information at their own
pace.
 Educating patient’s ahead of time to decrease the time providers
must spend on education of a complicated topic during the office
visit.
 Potential to create circular discussion between providers and
patients

Future
Recommendat
ions

 Recommendations change constantly as new evidence emerges
and new clinical tools are found and evaluated. Patient education
materials will have to change with new understanding of prostate
cancer screening.
 Assess efficacy of handout by Family Physicians. Does the
information help patient’s feel comfortable in their decision or
generate more questions and anxiety around making and living
with a choice?

 “AUA Guideline: Early Detection of Prostate Cancer.” American
Urological Association - Early Detection of Prostate Cancer, 2015.
www.auanet.org/guidelines/early-detection-of-prostate-cancer(2013-reviewed-and-validity-confirmed-2015).
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